At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 40 enrolled
Drug / intervention
botulinum toxin Type A +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Glabellar Lines - Establishing Patient Satisfaction
In Brief
A Phase 4 clinical trial evaluating botulinum toxin Type A and normal saline (placebo) for Glabellar Frown Lines. Completed, enrolled 40 participants across 1 site.
Detailed Summary
This was a pilot study to observe patient satisfaction with BOTOX® Cosmetic treatment in glabellar rhytides (frown lines) using a new treatment satisfaction measure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlabellar Frown Lines
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedJul 2011
Primary CompletionOct 2011
TodayJul 2026
First PostedJul 12, 2011
Enrollment StartJun 1, 2011
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.0 years ago
Interventions
botulinum toxin Type Abiological
botulinum toxin Type A 20U (total dose) injected into the glabellar region on Day 0.
normal saline (placebo)drug
Normal saline (placebo) injected into the glabellar region on Day 0.